Popular Science published an in-depth look at Potbotics, based in New York City. The company is focused on developing technology solutions to help medical cannabis patients make more informed decisions about which strains to use.
To the founders of Potbotics, that’s where they come in. This week the company launches PotBot, a free online tool designed to bring much of this scientific information to patients in order to help them better understand which cannabinoids are best for their specific medical conditions.
Users enter their age, weight, frequency of marijuana use, and medical condition, and the site spits out suggestions of which cannabinoid concentration and marijuana strains would be best to treat them. Each recommendation contains links to the peer-reviewed studies to support the recommendation. And in cases where information is scarce, or the supplementary studies were conducted on mice, for example—the caveats appear in a pop-up window.
If you were to go to some of PotBot’s competitors, they focus on a strain’s recreational attributes: taste, flavor, smell.
David Goldstein, CEO of Potbotics
Read Alexanda Ossola’s “This Startup Wants To Put The ‘medical’ Back In Marijuana”: http://www.popsci.com/potbotics-wants-to-put-medical-back-in-marijuana
